Disclaimer: Information in this article is strictly for informational purposes. SOLVE is a utility token and discussion is strictly around utility. This is not financial advice.

The landscape of clinical trials is on the brink of a transformative revolution, and at the heart of this revolution is Care.Trials, a groundbreaking healthcare network powered by the SOLVE token.

Unlike traditional clinical trial platforms, Care.Trials introduces a novel tokenomics model that not only enhances the efficiency of trials but also creates a substantial demand for the SOLVE token as its utility grows.

The Traditional Cost Challenge

Over the past decade, the cost of clinical trials has seen a staggering increase. The average cost of enrolling a single patient is expected to rise by at least 16% in the next ten years.

With trial sizes ranging from 100 to 4,000 participants and costs escalating from millions to tens of millions, the traditional model is financially burdensome for pharmaceutical companies and clinical research organizations (CROs).

At Solve.Care, we are finding solutions to these issues and utilizing the SOLVE token as the currency of Care.Trials.

Enter Care.Trials, the first healthcare network priced in a digital token — SOLVE.

This innovative approach creates a financial incentive for enterprises to accumulate SOLVE tokens upfront.

In the Care.Trials ecosystem, SOLVE tokens become the currency for paying for clinical trials. This shift forces and incentivizes stakeholders to buy bulk SOLVE upfront, making it an integral part of their inventory.

It also forces the accumulation of SOLVE tokens by enterprises.

The tokenomics of Care.Trials are poised to change how enterprises approach clinical trials. With the demand for SOLVE tokens tied directly to trial participation, pharmaceutical companies and CROs have a financial reason to accumulate SOLVE.

This unique approach transforms SOLVE into a practical and necessary resource for conducting clinical research.

Market Size and Growing Demand

The overall market size for clinical trials is enormous and continually growing. In the last ten years, approximately $440 billion was spent on recruiting about 61 million patients in 55,000 trials. Projections for the next decade estimate spending of $1.15 trillion for recruiting about 136 million patients in 138,000 trials. The acute pain points in traditional trial recruitment create a compelling incentive for a disruptive solution.

Care.Trials Impact on the Industry

1. Cost Reduction: Care.Trials has the potential to reduce spending on recruitment by half, saving the pharma industry up to $576 billion in the next ten years.
2. Trial Duration: By shortening the average trial duration from 28 months to 25 months, Care.Trials prevents the pharma industry from losing up to $79.3 trillion in revenue in the next 25 years.
3. Achieving Recruitment Targets: Care.Trials aims to help 8.8 million clinical trial sites achieve their recruitment targets in the next ten years, conserving an additional $146 billion for Pharma sponsors.
4. Improve Global Healthcare community: Care.Trials are bringing the global community as a powerful force to eradicate chronic diseases, prolong life, cure cancer, delay aging, make a difference and help advance medical progress together. And it is the SOLVE token that powers this innovation.

The financial dynamics introduced by Care.Trials not only streamline the clinical trial process but also position SOLVE as an indispensable asset in the healthcare industry’s future. As the world of clinical trials evolves, the demand for SOLVE tokens is set to soar, marking a new era in the intersection of healthcare and blockchain technology.

SOLVE is a catalyst for industry transformation.

The SOLVE token, with its intrinsic link to Care.Trials, becomes a catalyst for transformative changes in the pharmaceutical and clinical research industry. Here’s how SOLVE is more than just a digital currency:

1. Efficiency Through Blockchain: Care.Trials leverages blockchain technology to ensure data integrity, transparency, and security throughout the trial journey. This not only streamlines the clinical trial process but also mitigates risks associated with data manipulation and fraud.
2. Predictable Costs with Tokenomics: By pricing trials in SOLVE tokens, the costs become more predictable for enterprises. This innovative approach introduces a level of financial stability that is absent in traditional fiat-based models, allowing for more accurate budgeting and financial planning.
3. Incentivizing Bulk SOLVE Purchases: The Care.Trials model incentivizes enterprises to purchase SOLVE tokens in bulk. This strategic move not only secures their participation in the network but also aligns their financial interests with the success of Care.Trials, creating a symbiotic relationship between stakeholders and the SOLVE token.
4. Future-Proofing Clinical Research: As the healthcare industry undergoes a paradigm shift with the integration of blockchain technology, SOLVE emerges as a future-proof token. Its demand is not just limited to Care.Trials; it represents a broader trend toward blockchain adoption in healthcare, positioning SOLVE as a valuable token in the evolving landscape.
5. Decentralized Nature of Blockchain: The decentralized nature of blockchain ensures that SOLVE transactions are secure, transparent, and tamper-proof. This level of security is paramount in healthcare, where the integrity of patient data and trial results is of utmost importance.
6. Empowering Participants with Token Rewards: Care.Trials goes beyond cost efficiency; it introduces a novel way to reward participants with SOLVE tokens. This not only incentivizes trial participation but also creates a token circulation loop within the ecosystem, fostering a vibrant and engaged community.

As you can see, the SOLVE has a bright future as the utility token that powers Clinical Trials world-wide.

The introduction of Care.Trials and the integration of the SOLVE token mark a turning point in the evolution of clinical trials. This innovative model not only addresses the financial challenges of traditional trials but also aligns stakeholders’ interests with the success of the platform.

As Care.Trials gains traction, SOLVE becomes more than just a digital currency — it becomes a symbol of efficiency, transparency, and participant empowerment in clinical research. The growing demand for SOLVE tokens is not merely a reflection of speculative interest; it is a testament to the tangible impact blockchain is making in revolutionizing healthcare, one clinical trial at a time.

In the coming years, as Care.Trials disrupts the clinical trial landscape, SOLVE is poised to emerge as a cornerstone in the financial infrastructure of healthcare research, bringing us closer to a future where clinical trials are efficient, transparent, and accessible to all. The journey has just begun, and SOLVE is leading the way.

(Source Data: 1. Examination of Clinical Trial Costs and Barriers for Drug Development | ASPE (hhs.gov) // 2. Search for: Completed studies, Interventional studies, Study completion from 01/01/2013 to 12/09/2023 | Card Results | ClinicalTrials.gov // 3. DI_Intelligent-clinical-trials.pdf (deloitte.com)

Your Solve.Care Team.